首页> 美国卫生研究院文献>BMC Nephrology >Serum C1q- binding adiponectin in maintenance hemodialysis patients
【2h】

Serum C1q- binding adiponectin in maintenance hemodialysis patients

机译:维持性血液透析患者的血清C1q结合脂联素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPatients on maintenance hemodialysis (HD) have much higher levels of adiponectin (Total-APN). Adiponectin and C1q form a protein complex in human blood, and serum C1q-binding adiponectin (C1q-APN) can be measured. We recently reported that C1q-APN/Total-APN ratio rather than Total-APN correlated with atherosclerosis in diabetics. However, the characteristics of C1q-APN in HD patients remain unclear. The preset study investigated the characteristics of the adiponectin parameters including C1q-APN and also to clarify the relationship between various serum adiponectin parameters and atherosclerotic cardiovascular diseases (ACVD) in HD patients.
机译:背景维持性血液透析(HD)患者的脂联素(Total-APN)水平要高得多。脂联素和C1q在人血中形成蛋白质复合物,可以测定血清C1q结合脂联素(C1q-APN)。我们最近报道,糖尿病患者中C1q-APN /总APN比值而非总APN与动脉粥样硬化相关。然而,HD患者中C1q-APN的特征仍不清楚。预设研究调查了包括C1q-APN在内的脂联素参数的特征,并阐明了HD患者中各种血清脂联素参数与动脉粥样硬化性心血管疾病(ACVD)之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号